Preferential access vs competitors, relief on section 301 tariffs to top agenda of Indian negotiators during India-US trade talks: Sources
New Delhi, June 1
Indian negotiators will focus on securing preferential market access against competitors during talks with the visiting US team to finalise the bilateral trade agreement, sources said on Monday.
The sources told ANI that trade relief from US Section 301 investigations will also be on the top of the agenda with US trade team.
The talks, scheduled June 1-4, are led by US Chief Negotiator Brendan Lynch and India's Additional Secretary Darpan Jain.
According to the Ministry of Commerce, the round will finalise details of the interim pact and advance negotiations under the broader BTA on market access, non-tariff measures, customs and trade facilitation, investment promotion and economic security alignment.Union Commerce Minister Piyush Goyal, speaking during the operationalisation of the India-Oman CEPA, said the framework is being completed. "As far as the US team is concerned, some people have come, some will come tonight. Two, three and four, our meeting is going to be going on for three days," Goyal said.
"By the way, on February 3, the leaders of both countries announced the framework agreement. All the big things are decided."Goyal said only technical issues remain. "As you know, just now, the US ambassador, Sergio Gore, also said that 99% of the things have been decided. Small commas and full stops are being discussed. While finalizing, the changes that came there, the legal changes that came in the US, how to reflect that in the final agreement, how to change accordingly, after deciding that, I have complete faith that even with the USA, as soon as possible, we will end the first tranche of the bilateral trade agreement, sign it, and start the discussion on how to make bilateral trade agreements in the future."
The current round follows an Indian delegation visit to Washington from April 20-23 led by Jain. It builds on the Joint Statement issued Feb 7, 2026, where both sides agreed on a framework for an Interim Agreement focused on reciprocal trade while reaffirming commitment to a comprehensive BTA.
Under that framework, India proposed to eliminate or reduce tariffs on US industrial goods and a range of agricultural products including dried distillers' grains, red sorghum, tree nuts, fresh and processed fruit, soybean oil, wine and spirits.
US Ambassador Sergio Gor, speaking Friday at the US-India TRUST Initiative at IIT Delhi, said the conclusion is imminent. "Just last week, India had sent a team to Washington DC to finalise the last 1 per cent of that trade deal. Next week we will welcome a U.S. delegation here to continue those talks," he said.
"We fully expect that the trade deal will be signed over the next few weeks and months." Bilateral trade in goods and services has grown from USD 20 billion to over USD 220 billion in two decades, Gore noted, with India now seen as a cornerstone strategic ally for Washington.
— ANI
Reader Comments
US wants access to our market, we want relief from their tariffs. Fair trade should be exactly that - fair. Hope our negotiators play smart and don't agree to anything that hurts our domestic industries. Piyush Goyal seems confident, but details matter.
Bilateral trade growing from $20 billion to $220 billion in 20 years is impressive. But why are we offering tariff cuts on wine and spirits? That's luxury consumption, not a necessity. Focus should be on what helps our industry and common people.
"99% things decided" - that's what they said last time too! 😅 But seriously, India-US trade relationship is crucial. Section 301 relief will help our IT and pharma sectors a lot. Let's just hope the fine print doesn't have any hidden surprises.
I appreciate the diplomatic progress, but why is India so eager to sign an interim agreement? Shouldn't we take time to ensure all terms benefit our economy? Also, reducing tariffs on agricultural products concerns me - our farmers already struggle enough.
The India-Oman CEPA and now US talks - our trade diplomacy is getting stronger! If we can get preferential access against competitors like China and Vietnam, that's a big win. But need vigilance on intellectual property clauses - our generic pharma must be protected.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.